| K-number | K254021 |
| Device name | Accuro XV |
| Applicant | Rivanna Medical, Inc. |
| Product code | IYO |
| Device class | Class II |
| Decision date | Apr 9, 2026 |
| Decision | Substantially Equivalent |
| Regulation | 892.1560 |
The Accuro XV is a portable ultrasound imaging system for use by qualified healthcare professionals in hospital or clinic settings. It features a conformable three-dimensional ultrasound probe with motorized scanning that automates large field-of-view image acquisitions for musculoskeletal conventional and superficial imaging applications.
The key difference is the Accuro XV volumetric imaging probe, which contains a 384-element linear array at 6.5 MHz center frequency with 360-micron pitch. Volumetric scans are automatically acquired via motorized linear translation over 10 cm, and a compliant polyurethane stand-off medium provides a conformable patient contact surface. The predicate (Accuro 3S) uses a Dual-Array convex probe, while the reference device (Logiq E9) uses mechanically similar three-dimensional probes with differences in geometry, patient contact material, and conformability.
IEC 60601-1 Edition 3.2, IEC 60601-1-2 Edition 4.1, IEC 60601-1-6 Edition 3.2, IEC 60601-2-37 Edition 2.1, IEC 62304, IEC 62366-1, IEC 62359, ISO 10993-1, ISO 14971, NEMA UD 2-2004, NEMA PS 3.1-3.20e (DICOM), and AAMI TIR69:2017.
Accuro XV is substantially equivalent to the predicate Accuro 3S and reference device Logiq E9 because it shares the same intended use, intended user, patient population, and clinical applications. Non-clinical testing demonstrates acoustic output, safety, cleaning/disinfection, electrical, thermal, mechanical, and EMC compliance with applicable standards. The probe geometry and material differences do not raise new safety or effectiveness issues, supported by risk management and performance validation testing.
View the full FDA submission: accessdata.fda.gov